The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers

International Journal of Cancer

Volumn 86, Issue 1, 2000, Pages 101-107

  Tunggal, Jonathan K ^a   Melo, Tricia ^a   Ballinger, James R ^b   Tannock, Ian F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; VERAPAMIL;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG PENETRATION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARBON RADIOISOTOPES; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MODELS, BIOLOGICAL; P-GLYCOPROTEIN; RADIOPHARMACEUTICALS; SARCOMA, EXPERIMENTAL; SUCROSE; TECHNETIUM TC 99M SESTAMIBI; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0034007524     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000401)86:1<101::AID-IJC16>3.0.CO;2-I     Document Type: Article

References (25)

1. BOESCH, D., MULLER, K., POURTIER-MANZANEDO, A. and LOOR, F., Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative. Exp. Cell Res., 196, 26-32 (1991).
2. COWAN, D.S.M., HICKS, K.O. and WILSON, W.R., Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Brit. J. Cancer, 74 (Supp. 27), 528-531 (1996).
3. DURAND, R.E., Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro. Cancer Res., 41, 3495-3498 (1981).
4. DURAND, R.E., Distribution and activity of antineoplastic drugs in a tumor model. J. nat. Cancer. Inst., 81, 146-152 (1989).
5. DURAND, R.E., Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage? Cancer Chemother. Pharmacol., 26, 198-204 (1990).
6. ENDICOTT, J.A. and LING, V., The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann. Rev. Biochem., 58, 137-171 (1989).
7. FAIRCHILD, C.R., MOSCOW, J.A., O'BRIEN, E.E. and COWAN, K.H., Multidrug resistance in cells transfected with human genes encoding variant P-glycoprotein and glutathione-S-transferase-pi. Mol. Pharmacol., 37, 801-809 (1990).
8. FOJO, A., UEDA, K., SALMON, D.J., POPLACK, D.G., GOTTESMAN, M.M. and PASTAN, I., Expression of a multidrug-resistance gene in human tumours and tissues. Proc. nat. Acad. Sci. (Wash.), 84, 265-269 (1987).
9. HICKS, K.O., OHMS, S.J., VAN ZUL, P.L., DENNY, W.A., HUNTER, P.J. and WILSON, W.R., An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. Br. J. Cancer, 76, 894-903 (1997).
10. HYAFIL, F., VERGELY, C., DU VIGNAUD, P. and GRAND-PERRET, T., In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res., 53, 4595-4602 (1993).
11. JAIN, R.K., Vascular and interstitial barriers to delivery of therapeutic agents in tumors [Review]. Cancer Metastasis Rev., 9, 253-266 (1990).
12. KERR, D.J. and KAYE, S.B., Aspects of cytotoxic drug penetration, with particular reference to anthracyclines. Cancer Chemother. Pharmacol., 19, 1-5 (1987).
13. NEDERMAN, T., CARLSSON, J. and KUOPPA, K., Penetration of substances into tumour tissue. Model studies using saccharides, thymidine and thymidine-5′-triphosphate in cellular spheroids. Cancer Chemother. Pharmacol., 22, 21-25 (1988).
14. NEDERMAN, T., CARLSSON J. and MALMQUIST, M., Penetration of substances into tumour tissue. A methodological study on cellular spheroids. In Vitro, 17, 240-298 (1981).
15. NICHOLSON, K.M., BIBBY, M.C. and PHILLIPS, R.M., Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids. Europ. J. Cancer, 33, 1291-1298 (1997).
16. PIWNICA-WORMS, D., CHIU, M.L., BUDDING, M., KRONAUGE, J.F, KRAMER, R.A. and CROOP, J.M., Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res., 53, 977-984 (1993).
17. TANNOCK, I.F. and ROTIN, D., Acid pH in tumours and its potential for therapeutic exploitation. Cancer Res., 49, 4373-4384 (1989).
18. TSURUO, T., IIDA, H., TSUKAGOSHI, S. and SAKURAI, J., Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res., 41, 1967-1972 (1981).
19. TSURUO, T., SUGIMOTO, Y., HAMADA, H., RONINSON, I., OKUMURA., M., ADACHI, K., MORISHIMA, Y. and OHNO, R., Detection of multidrug resistance markers. P-glycoprotein, an MDR1 mRNA, in human leukemia cells. Jpn. J. Cancer Res., 78, 1415-1419 (1987).
20. TUNGGAL, J.K, BALLINGER, J.R. and TANNOCK, I.F., Influence of cell concentration in limiting the therapeutic benefit of P-glycoprotein reversal agents. Int. J. Cancer. 81, 741-747 (1999a).
21. TUNGGAL, J.K, COWAN, D.S.M., SHAIKH, H. and TANNOCK, I.F., Penetration of anticancer drugs through solid tissue: a factor which limits the effectiveness of chemotherapy for solid tumors. Clin. Cancer Res., 5, 1583-1586 (1999b).
22. TWENTYMAN, P.R., FOX, N.E. and WHITE, D.J.G., Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multidrug resistant human lung cancer cell line. Brit. J. Cancer. 56, 55-57 (1987).
23. TWENTYMAN, P.R., REEVE, J.G., KOCH, G. and WRIGHT, K.A., Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprolein and CP22 (sorcin). Brit. J. Cancer, 62, 89-95 (1990).
24. VUKOVIC, V. and TANNOCK, I.F., Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan. Brit. J. Cancer, 75, 1167-1172 (1997).
25. WEST, G.W., WEICHSELBAUM, R. and LITTLE, J.B., Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy. Cancer Res., 40, 3665-3668 (1980).